1. Home
  2. LIN vs ABT Comparison

LIN vs ABT Comparison

Compare LIN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Linde plc

LIN

Linde plc

HOLD

Current Price

$409.43

Market Cap

217.0B

Sector

Industrials

ML Signal

HOLD

Logo Abbott Laboratories

ABT

Abbott Laboratories

HOLD

Current Price

$129.07

Market Cap

222.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIN
ABT
Founded
1879
1888
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
217.0B
222.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIN
ABT
Price
$409.43
$129.07
Analyst Decision
Buy
Strong Buy
Analyst Count
11
18
Target Price
$504.40
$146.61
AVG Volume (30 Days)
2.9M
6.6M
Earning Date
10-31-2025
10-15-2025
Dividend Yield
1.46%
1.83%
EPS Growth
13.37
141.97
EPS
14.94
7.96
Revenue
$33,504,000,000.00
$43,843,000,000.00
Revenue This Year
$3.68
$7.55
Revenue Next Year
$5.54
$7.70
P/E Ratio
$27.46
$16.19
Revenue Growth
1.45
6.37
52 Week Low
$406.09
$110.86
52 Week High
$486.38
$141.23

Technical Indicators

Market Signals
Indicator
LIN
ABT
Relative Strength Index (RSI) 31.75 53.60
Support Level $406.09 $126.23
Resistance Level $412.87 $129.52
Average True Range (ATR) 6.44 2.72
MACD 0.30 0.31
Stochastic Oscillator 13.11 70.24

Price Performance

Historical Comparison
LIN
ABT

About LIN Linde plc

Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $33 billion in revenue in 2024.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Share on Social Networks: